Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-09 6:33 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 3,371,301 4.8% | 116,210 (+3.57%) | View |
| 2021-02-16 4:43 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | Boxer Capital LLC | 2,084,883 3.2% | -937,508 (-31.02%) | View |
| 2021-02-16 4:10 pm Unchanged | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 3,373,460 5.2% | 0 (Unchanged) | View |
| 2021-02-02 4:51 pm Sale | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC. GILD | 22,723,156 35% | -6,775,268 (-22.97%) | View |
| 2021-02-02 2:56 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 3,255,091 5% | 763,110 (+30.62%) | View |
| 2020-12-10 5:16 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,222 4.2% | -826,801 (-23.10%) | View |
| 2020-11-09 4:01 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 3,373,460 5.2% | 3,373,460 (New Position) | View |
| 2020-11-04 4:52 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | COLUMN GROUP II LP | 0 0% | -3,540,850 (Position Closed) | View |
| 2020-10-15 4:42 pm Sale | 13D | ARCUS BIOSCIENCES INC RCUS | Jaen Juan C. | 1,894,967 2.92% | -1,144,499 (-37.65%) | View |
| 2020-07-17 2:01 pm Purchase | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC. GILD | 29,498,424 35% | 29,498,424 (New Position) | View |
| 2020-06-09 4:32 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 2,491,981 4.4% | -516,781 (-17.18%) | View |
| 2020-03-05 4:44 pm Purchase | 13D | ARCUS BIOSCIENCES INC RCUS | Jaen Juan C. | 3,039,466 6.62% | 3,039,466 (New Position) | View |
| 2020-03-05 4:41 pm Purchase | 13D | ARCUS BIOSCIENCES INC RCUS | ROSEN TERRY J | 4,292,740 9.34% | 4,292,740 (New Position) | View |
| 2020-02-14 2:59 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 3,579,023 7.8% | 1,167,400 (+48.41%) | View |
| 2020-02-13 3:05 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | Boxer Capital LLC | 3,022,391 6.6% | 3,022,391 (New Position) | View |
| 2020-02-07 08:45 am Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 3,008,762 6.6% | 3,008,762 (New Position) | View |
| 2020-01-27 3:36 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -4,283,334 (Position Closed) | View |